These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

130 related articles for article (PubMed ID: 23564768)

  • 1. Characterization and evaluation of pre-clinical suitability of a syngeneic orthotopic mouse ovarian cancer model.
    Cho S; Sun Y; Soisson AP; Dodson MK; Peterson CM; Jarboe EA; Kennedy AM; Janát-Amsbury MM
    Anticancer Res; 2013 Apr; 33(4):1317-24. PubMed ID: 23564768
    [TBL] [Abstract][Full Text] [Related]  

  • 2. An immunocompetent, orthotopic mouse model of epithelial ovarian cancer utilizing tissue engineered tumor cell sheets.
    Arauchi A; Yang CH; Cho S; Jarboe EA; Peterson CM; Bae YH; Okano T; Janát-Amsbury MM
    Tissue Eng Part C Methods; 2015 Jan; 21(1):23-34. PubMed ID: 24745555
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Epithelial-stromal interaction increases cell proliferation, survival and tumorigenicity in a mouse model of human epithelial ovarian cancer.
    Greenaway J; Moorehead R; Shaw P; Petrik J
    Gynecol Oncol; 2008 Feb; 108(2):385-94. PubMed ID: 18036641
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Ovarian tumour growth is characterized by mevalonate pathway gene signature in an orthotopic, syngeneic model of epithelial ovarian cancer.
    Greenaway JB; Virtanen C; Osz K; Revay T; Hardy D; Shepherd T; DiMattia G; Petrik J
    Oncotarget; 2016 Jul; 7(30):47343-47365. PubMed ID: 27329838
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Orthotopic, syngeneic mouse model to study the effects of epithelial-stromal interaction.
    Greenaway JB; Petrik JJ
    Methods Mol Biol; 2013; 1049():409-23. PubMed ID: 23913234
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Proliferation and maturation of intratumoral blood vessels in women with malignant ovarian tumors assessed with cancer stem cells marker nestin and platelet derived growth factor PDGF-B.
    Czekierdowska S; Stachowicz N; Chróściel M; Czekierdowski A
    Ginekol Pol; 2017; 88(3):120-128. PubMed ID: 28397199
    [TBL] [Abstract][Full Text] [Related]  

  • 7. ABT-510 induces tumor cell apoptosis and inhibits ovarian tumor growth in an orthotopic, syngeneic model of epithelial ovarian cancer.
    Greenaway J; Henkin J; Lawler J; Moorehead R; Petrik J
    Mol Cancer Ther; 2009 Jan; 8(1):64-74. PubMed ID: 19139114
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Dietary energy balance modulates ovarian cancer progression and metastasis.
    Al-Wahab Z; Tebbe C; Chhina J; Dar SA; Morris RT; Ali-Fehmi R; Giri S; Munkarah AR; Rattan R
    Oncotarget; 2014 Aug; 5(15):6063-75. PubMed ID: 25026276
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Crosstalk between TEMs and endothelial cells modulates angiogenesis and metastasis via IGF1-IGF1R signalling in epithelial ovarian cancer.
    Wang X; Zhu Q; Lin Y; Wu L; Wu X; Wang K; He Q; Xu C; Wan X; Wang X
    Br J Cancer; 2017 Oct; 117(9):1371-1382. PubMed ID: 28898232
    [TBL] [Abstract][Full Text] [Related]  

  • 10. CXCL10 alters the tumour immune microenvironment and disease progression in a syngeneic murine model of high-grade serous ovarian cancer.
    K Au K; Peterson N; Truesdell P; Reid-Schachter G; Khalaj K; Ren R; Francis JA; Graham CH; Craig AW; Koti M
    Gynecol Oncol; 2017 Jun; 145(3):436-445. PubMed ID: 28318643
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Modification of the Tumor Microenvironment in KRAS or c-MYC-Induced Ovarian Cancer-Associated Peritonitis.
    Yoshida M; Taguchi A; Kawana K; Adachi K; Kawata A; Ogishima J; Nakamura H; Fujimoto A; Sato M; Inoue T; Nishida H; Furuya H; Tomio K; Arimoto T; Koga K; Wada-Hiraike O; Oda K; Nagamatsu T; Kiyono T; Osuga Y; Fujii T
    PLoS One; 2016; 11(8):e0160330. PubMed ID: 27483433
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Syngeneic Murine Ovarian Cancer Model Reveals That Ascites Enriches for Ovarian Cancer Stem-Like Cells Expressing Membrane GRP78.
    Mo L; Bachelder RE; Kennedy M; Chen PH; Chi JT; Berchuck A; Cianciolo G; Pizzo SV
    Mol Cancer Ther; 2015 Mar; 14(3):747-56. PubMed ID: 25589495
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Fibroblast recruitment as a tool for ovarian cancer detection and targeted therapy.
    Oren R; Addadi Y; Narunsky Haziza L; Dafni H; Rotkopf R; Meir G; Fishman A; Neeman M
    Int J Cancer; 2016 Oct; 139(8):1788-98. PubMed ID: 27242346
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Isolation and characterization of stromal progenitor cells from ascites of patients with epithelial ovarian adenocarcinoma.
    Ho CM; Chang SF; Hsiao CC; Chien TY; Shih DT
    J Biomed Sci; 2012 Feb; 19(1):23. PubMed ID: 22330345
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Upregulation of IGF1 by tumor-associated macrophages promotes the proliferation and migration of epithelial ovarian cancer cells.
    Liu L; Wang X; Li X; Wu X; Tang M; Wang X
    Oncol Rep; 2018 Feb; 39(2):818-826. PubMed ID: 29251331
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A novel mechanism of neovascularization in peritoneal dissemination via cancer-associated mesothelial cells affected by TGF-β derived from ovarian cancer.
    Fujikake K; Kajiyama H; Yoshihara M; Nishino K; Yoshikawa N; Utsumi F; Suzuki S; Niimi K; Sakata J; Mitsui H; Shibata K; Senga T; Kikkawa F
    Oncol Rep; 2018 Jan; 39(1):193-200. PubMed ID: 29192324
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Slug Is Associated With Tumor Metastasis and Angiogenesis in Ovarian Cancer.
    Gu A; Jie Y; Yao Q; Zhang Y; Mingyan E
    Reprod Sci; 2017 Feb; 24(2):291-299. PubMed ID: 27368877
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Fusion-derived epithelial cancer cells express hematopoietic markers and contribute to stem cell and migratory phenotype in ovarian carcinoma.
    Ramakrishnan M; Mathur SR; Mukhopadhyay A
    Cancer Res; 2013 Sep; 73(17):5360-70. PubMed ID: 23856249
    [TBL] [Abstract][Full Text] [Related]  

  • 19. CD73 is associated with poor prognosis in high-grade serous ovarian cancer.
    Turcotte M; Spring K; Pommey S; Chouinard G; Cousineau I; George J; Chen GM; Gendoo DM; Haibe-Kains B; Karn T; Rahimi K; Le Page C; Provencher D; Mes-Masson AM; Stagg J
    Cancer Res; 2015 Nov; 75(21):4494-503. PubMed ID: 26363007
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cytokine profiling of ascites at primary surgery identifies an interaction of tumor necrosis factor-α and interleukin-6 in predicting reduced progression-free survival in epithelial ovarian cancer.
    Kolomeyevskaya N; Eng KH; Khan AN; Grzankowski KS; Singel KL; Moysich K; Segal BH
    Gynecol Oncol; 2015 Aug; 138(2):352-7. PubMed ID: 26001328
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.